ABBVIE ENDOCRINE Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABBVIE ENDOCRINE, and what generic alternatives to ABBVIE ENDOCRINE drugs are available?
ABBVIE ENDOCRINE has seven approved drugs.
There are two US patents protecting ABBVIE ENDOCRINE drugs.
There are thirty-five patent family members on ABBVIE ENDOCRINE drugs in twenty-eight countries.
Summary for ABBVIE ENDOCRINE
International Patents: | 35 |
US Patents: | 2 |
Tradenames: | 4 |
Ingredients: | 2 |
NDAs: | 7 |
Drugs and US Patents for ABBVIE ENDOCRINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-009 | Apr 14, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 019732-001 | Jan 26, 1989 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Abbvie Endocrine Inc | LUPRON | leuprolide acetate | INJECTABLE;INJECTION | 019010-001 | Apr 9, 1985 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Abbvie Endocrine | LUPANETA PACK | leuprolide acetate; norethindrone acetate | INJECTABLE, TABLET;INTRAMUSCULAR, ORAL | 203696-002 | Dec 14, 2012 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020011-002 | Oct 26, 1995 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ABBVIE ENDOCRINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-006 | Jan 21, 1994 | 4,954,298 | ⤷ Try a Trial |
Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-002 | Apr 16, 1993 | 5,716,640 | ⤷ Try a Trial |
Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-003 | Apr 16, 1993 | 5,575,987 | ⤷ Try a Trial |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020517-001 | Dec 22, 1995 | 5,631,020 | ⤷ Try a Trial |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020011-001 | Oct 22, 1990 | 5,631,021 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ABBVIE ENDOCRINE Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Malaysia | 148370 | ⤷ Try a Trial |
South Korea | 101522035 | ⤷ Try a Trial |
Morocco | 31006 | ⤷ Try a Trial |
Georgia, Republic of | P20125597 | ⤷ Try a Trial |
Japan | 2010513225 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.